Dr Reddy’s Laboratories has launched amlodipine benazepril capsules (2.5mg/10mg, 5mg/10mg, 5mg/20mg, 10mg/20mg), a bioequivalent generic version of Lotrel capsules, in the US market on April 23, 2010.

In September 2009, Dr Reddy’s had entered into a patent settlement with Novartis on amlodipine benazepril stipulating the dismissal of the lawsuits in the United States. The US FDA granted an approval of Dr Reddy’s ANDA for amlodipine benazepril on April 15, 2010.

Amlodipine benazepril is indicated for the treatment of hypertension in patients not adequately controlled with either agent and is taken once daily. Dr Reddy’s product is available in bottles of 100 count capsules.